John Cox

CEO

John previously served as CEO of Torque Therapeutics, which combined with Cogen Immune Medicine to form Repertoire. Prior to that, Mr. Cox served as CEO of Bioverativ, leading its spin-out from Biogen in 2016 through its acquisition by Sanofi in 2018. Previously, he held several senior executive positions at Biogen from 2003 to 2016, most recent...

Roles at Repertoire Immune Medicines

  • CEO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.